Bernd Elger Selected Research

2,3- dimethyl- 6- phenyl- 12H- (1,3)dioxolo(4,5- h)imidazo(1,2- c)(2,3)benzodiazepine

10/2006	Optimized synthesis of AMPA receptor antagonist ZK 187638 and neurobehavioral activity in a mouse model of neuronal ceroid lipofuscinosis.
4/2006	Extended therapeutic time window after focal cerebral ischemia by non-competitive inhibition of AMPA receptors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bernd Elger Research Topics

Disease

2	Endometriosis 03/2020 - 01/2020
2	Brain Ischemia (Cerebral Ischemia) 04/2006 - 07/2005
1	Iron Overload 01/2020
1	Pain (Aches) 01/2020
1	Neuronal Ceroid-Lipofuscinoses (Neuronal Ceroid Lipofuscinosis) 10/2006
1	Stroke (Strokes) 04/2006
1	Infarction (Infarctions) 04/2006
1	Motor Neuron Disease (Primary Lateral Sclerosis) 01/2006
1	Brain Infarction 07/2005
1	Ischemic Stroke 07/2005

Drug/Important Bio-Agent (IBA)

4	AMPA Receptors (AMPA Receptor)IBA 10/2006 - 07/2005
2	AminesIBA 03/2020 - 01/2020
2	Oxidoreductases (Dehydrogenase)IBA 03/2020 - 01/2020
2	2,3- dimethyl- 6- phenyl- 12H- (1,3)dioxolo(4,5- h)imidazo(1,2- c)(2,3)benzodiazepineIBA 10/2006 - 04/2006
2	Glutamic Acid (Glutamate)FDA Link 04/2006 - 01/2006
1	Analgesics (Analgesic Drugs)IBA 01/2020
1	Hemoglobins (Hemoglobin)IBA 01/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 04/2006
1	Excitatory Amino Acid AntagonistsIBA 04/2006
1	Neuroprotective AgentsIBA 04/2006

Therapy/Procedure

1	Therapeutics 04/2006